@article{9871b6c3d7b14f328b4c0b94fe8fa505,
title = "Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986",
abstract = "This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ({"}unfit{"}) for cisplatin chemotherapy.",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Cisplatin, Deoxycytidine, Female, Humans, Male, Methotrexate, Middle Aged, Quality of Life, Questionnaires, Survival Rate, Urologic Neoplasms, Vinblastine",
author = "{De Santis}, Maria and Joaquim Bellmunt and Graham Mead and Kerst, {J Martijn} and Michael Leahy and Pablo Maroto and Thierry Gil and Sandrine Marreaud and Gedske Daugaard and Iwona Skoneczna and Sandra Collette and Julie Lorent and {de Wit}, Ronald and Richard Sylvester",
year = "2012",
doi = "10.1200/JCO.2011.37.3571",
language = "English",
volume = "30",
pages = "191--9",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "2",
}